Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd

This early-stage study is testing an experimental cell therapy called SYS6055 in adults with aggressive B-cell lymphoma that has returned or not responded to standard treatments. The main goals are to find a safe dose, check for side effects, and see if the treatment shows early …